A six-month audit of the isolation of Fusobacterium necrophorum from patients with sore throat in a district general hospital
Fusobacterium necrophorum is an obligate anaerobe believed to be a member of the normal flora of the human oropharangeal and urogenital tract. It has been associated with deep-seated infections and was first described in 1936 by Lemierre, a French microbiologist. There is now strong evidence to sugg...
Gespeichert in:
Veröffentlicht in: | British journal of biomedical science 2007-01, Vol.64 (2), p.63-65 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 65 |
---|---|
container_issue | 2 |
container_start_page | 63 |
container_title | British journal of biomedical science |
container_volume | 64 |
creator | Amess, J.A. O'neill, W. Giollariabhaigh, Ni Dytrych, J.K. |
description | Fusobacterium necrophorum is an obligate anaerobe believed to be a member of the normal flora of the human oropharangeal and urogenital tract. It has been associated with deep-seated infections and was first described in 1936 by Lemierre, a French microbiologist. There is now strong evidence to suggest that it is also a cause of recurrent sore throat and persistent sore throat syndrome (PSTS) without leading to full systemic infection. It is considered to be the second most common cause of sore throat after group A β-haemolytic streptococci. This study was performed over a six-month period (October 2004 to March 2005) at the Eastbourne District General Hospital. All throat swabs received in the laboratory are cultured routinely for haemolytic group A streptococci and pathogenic Corynebacteria spp. During the study period an extra fastidious anaerobic blood agar plate with neomycin was inoculated, with a 30 µg vancomycin disc placed at the junction of the second and third streaks. This was examined after 48 h for the presence of F. necrophorum. A total of 1157 swabs were processed during the study period: 156 were positive for haemolytic group A streptococci, 57 were positive for F. necrophorum, 47 for group C haemolytic streptococci, nine for group G haemolytic streptococci, and one was positive for C. ulcerans. Patient age ranged from less than a year old to 88. The majority of F. necrophorum isolates were from patients in the 11-25 age group, with an isolation rate of 9.48% (44/464). This age group accounted for 40% (464/1157) of the swabs received during the study period and 77% (44/57) of these were positive for F. necrophorum. Group A haemolytic streptococci showed an overall isolation rate of 13.5%, with peaks of 23% in the 0-10 and 26-35 age ranges. Together, these two organisms were responsible for 18.4% (213/1157) of all throat infections in this study. The results presented here indicate that F. necrophorum is second to group A haemolytic streptococci as a cause of sore throat, especially in the young adult, and introduction of routine culture should be considered. |
doi_str_mv | 10.1080/09674845.2007.11732757 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_09674845_2007_11732757</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1448299581</sourcerecordid><originalsourceid>FETCH-LOGICAL-c394t-9e0ca66a08ac53f6f20fd211cc6a731033285b5b6b2f92df8628b32c9ad732713</originalsourceid><addsrcrecordid>eNqFkc1u1DAURi0EotPCK1QWC3YZ_JPY8XJUUUCqxAbW1o1jM64SO9iOShd99zqaqZDYsLJlnfv56jsIXVOyp6Qnn4gSsu3bbs8IkXtKJWeyk6_QjrWybUivxGu026Bmoy7QZc73hFDFpHiLLqgUnFOudujpgLP_08wxlCOGdfQFR4fL0WKf4wTFx7A93K45DmCKTX6dcbAmxeUYU727FGe8VNCGkvGDrzE5JlsjUoSCfcCAR59L8qbgXzbYBBM-xrz4AtM79MbBlO3783mFft5-_nHztbn7_uXbzeGuMVy1pVGWGBACSA-m4044RtzIKDVGgOSUcM76bugGMTCn2Oh6wfqBM6Ng3Hqh_Ap9POUuKf5ebS569tnYaYJg45q1JJIRzroKfvgHvI9rCnU3zZhUrFbPKiROUG0h52SdXpKfIT1qSvRmR7_Y0Zsd_WKnDl6f09dhtuPfsbOOChxOgA8uphkeYppGXeBxisklCMZnzf_zyTPclqAz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>227920802</pqid></control><display><type>article</type><title>A six-month audit of the isolation of Fusobacterium necrophorum from patients with sore throat in a district general hospital</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Amess, J.A. ; O'neill, W. ; Giollariabhaigh, Ni ; Dytrych, J.K.</creator><creatorcontrib>Amess, J.A. ; O'neill, W. ; Giollariabhaigh, Ni ; Dytrych, J.K.</creatorcontrib><description>Fusobacterium necrophorum is an obligate anaerobe believed to be a member of the normal flora of the human oropharangeal and urogenital tract. It has been associated with deep-seated infections and was first described in 1936 by Lemierre, a French microbiologist. There is now strong evidence to suggest that it is also a cause of recurrent sore throat and persistent sore throat syndrome (PSTS) without leading to full systemic infection. It is considered to be the second most common cause of sore throat after group A β-haemolytic streptococci. This study was performed over a six-month period (October 2004 to March 2005) at the Eastbourne District General Hospital. All throat swabs received in the laboratory are cultured routinely for haemolytic group A streptococci and pathogenic Corynebacteria spp. During the study period an extra fastidious anaerobic blood agar plate with neomycin was inoculated, with a 30 µg vancomycin disc placed at the junction of the second and third streaks. This was examined after 48 h for the presence of F. necrophorum. A total of 1157 swabs were processed during the study period: 156 were positive for haemolytic group A streptococci, 57 were positive for F. necrophorum, 47 for group C haemolytic streptococci, nine for group G haemolytic streptococci, and one was positive for C. ulcerans. Patient age ranged from less than a year old to 88. The majority of F. necrophorum isolates were from patients in the 11-25 age group, with an isolation rate of 9.48% (44/464). This age group accounted for 40% (464/1157) of the swabs received during the study period and 77% (44/57) of these were positive for F. necrophorum. Group A haemolytic streptococci showed an overall isolation rate of 13.5%, with peaks of 23% in the 0-10 and 26-35 age ranges. Together, these two organisms were responsible for 18.4% (213/1157) of all throat infections in this study. The results presented here indicate that F. necrophorum is second to group A haemolytic streptococci as a cause of sore throat, especially in the young adult, and introduction of routine culture should be considered.</description><identifier>ISSN: 0967-4845</identifier><identifier>EISSN: 2474-0896</identifier><identifier>DOI: 10.1080/09674845.2007.11732757</identifier><identifier>PMID: 17633139</identifier><language>eng</language><publisher>England: Taylor & Francis</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Corynebacterium diphtheriae ; Diphtheria - diagnosis ; Disk Diffusion Antimicrobial Tests ; Female ; Fever ; Fusobacterium Infections - diagnosis ; Fusobacterium necrophorum ; Fusobacterium necrophorum - isolation & purification ; Hospitals ; Hospitals, District ; Hospitals, General ; Humans ; Infant ; Male ; Medical Audit - methods ; Middle Aged ; Patients ; Pharyngitis ; Pharyngitis - microbiology ; Pharynx - microbiology ; Prevalence ; Recurrence ; Streptococcal infections ; Streptococcal Infections - diagnosis ; Streptococcus pyogenes - isolation & purification ; Studies</subject><ispartof>British journal of biomedical science, 2007-01, Vol.64 (2), p.63-65</ispartof><rights>Copyright 2007 Taylor and Francis Group LLC 2007</rights><rights>Copyright Step Communications Ltd. 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c394t-9e0ca66a08ac53f6f20fd211cc6a731033285b5b6b2f92df8628b32c9ad732713</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17633139$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Amess, J.A.</creatorcontrib><creatorcontrib>O'neill, W.</creatorcontrib><creatorcontrib>Giollariabhaigh, Ni</creatorcontrib><creatorcontrib>Dytrych, J.K.</creatorcontrib><title>A six-month audit of the isolation of Fusobacterium necrophorum from patients with sore throat in a district general hospital</title><title>British journal of biomedical science</title><addtitle>Br J Biomed Sci</addtitle><description>Fusobacterium necrophorum is an obligate anaerobe believed to be a member of the normal flora of the human oropharangeal and urogenital tract. It has been associated with deep-seated infections and was first described in 1936 by Lemierre, a French microbiologist. There is now strong evidence to suggest that it is also a cause of recurrent sore throat and persistent sore throat syndrome (PSTS) without leading to full systemic infection. It is considered to be the second most common cause of sore throat after group A β-haemolytic streptococci. This study was performed over a six-month period (October 2004 to March 2005) at the Eastbourne District General Hospital. All throat swabs received in the laboratory are cultured routinely for haemolytic group A streptococci and pathogenic Corynebacteria spp. During the study period an extra fastidious anaerobic blood agar plate with neomycin was inoculated, with a 30 µg vancomycin disc placed at the junction of the second and third streaks. This was examined after 48 h for the presence of F. necrophorum. A total of 1157 swabs were processed during the study period: 156 were positive for haemolytic group A streptococci, 57 were positive for F. necrophorum, 47 for group C haemolytic streptococci, nine for group G haemolytic streptococci, and one was positive for C. ulcerans. Patient age ranged from less than a year old to 88. The majority of F. necrophorum isolates were from patients in the 11-25 age group, with an isolation rate of 9.48% (44/464). This age group accounted for 40% (464/1157) of the swabs received during the study period and 77% (44/57) of these were positive for F. necrophorum. Group A haemolytic streptococci showed an overall isolation rate of 13.5%, with peaks of 23% in the 0-10 and 26-35 age ranges. Together, these two organisms were responsible for 18.4% (213/1157) of all throat infections in this study. The results presented here indicate that F. necrophorum is second to group A haemolytic streptococci as a cause of sore throat, especially in the young adult, and introduction of routine culture should be considered.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Corynebacterium diphtheriae</subject><subject>Diphtheria - diagnosis</subject><subject>Disk Diffusion Antimicrobial Tests</subject><subject>Female</subject><subject>Fever</subject><subject>Fusobacterium Infections - diagnosis</subject><subject>Fusobacterium necrophorum</subject><subject>Fusobacterium necrophorum - isolation & purification</subject><subject>Hospitals</subject><subject>Hospitals, District</subject><subject>Hospitals, General</subject><subject>Humans</subject><subject>Infant</subject><subject>Male</subject><subject>Medical Audit - methods</subject><subject>Middle Aged</subject><subject>Patients</subject><subject>Pharyngitis</subject><subject>Pharyngitis - microbiology</subject><subject>Pharynx - microbiology</subject><subject>Prevalence</subject><subject>Recurrence</subject><subject>Streptococcal infections</subject><subject>Streptococcal Infections - diagnosis</subject><subject>Streptococcus pyogenes - isolation & purification</subject><subject>Studies</subject><issn>0967-4845</issn><issn>2474-0896</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkc1u1DAURi0EotPCK1QWC3YZ_JPY8XJUUUCqxAbW1o1jM64SO9iOShd99zqaqZDYsLJlnfv56jsIXVOyp6Qnn4gSsu3bbs8IkXtKJWeyk6_QjrWybUivxGu026Bmoy7QZc73hFDFpHiLLqgUnFOudujpgLP_08wxlCOGdfQFR4fL0WKf4wTFx7A93K45DmCKTX6dcbAmxeUYU727FGe8VNCGkvGDrzE5JlsjUoSCfcCAR59L8qbgXzbYBBM-xrz4AtM79MbBlO3783mFft5-_nHztbn7_uXbzeGuMVy1pVGWGBACSA-m4044RtzIKDVGgOSUcM76bugGMTCn2Oh6wfqBM6Ng3Hqh_Ap9POUuKf5ebS569tnYaYJg45q1JJIRzroKfvgHvI9rCnU3zZhUrFbPKiROUG0h52SdXpKfIT1qSvRmR7_Y0Zsd_WKnDl6f09dhtuPfsbOOChxOgA8uphkeYppGXeBxisklCMZnzf_zyTPclqAz</recordid><startdate>20070101</startdate><enddate>20070101</enddate><creator>Amess, J.A.</creator><creator>O'neill, W.</creator><creator>Giollariabhaigh, Ni</creator><creator>Dytrych, J.K.</creator><general>Taylor & Francis</general><general>Taylor & Francis Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>EHMNL</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20070101</creationdate><title>A six-month audit of the isolation of Fusobacterium necrophorum from patients with sore throat in a district general hospital</title><author>Amess, J.A. ; O'neill, W. ; Giollariabhaigh, Ni ; Dytrych, J.K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c394t-9e0ca66a08ac53f6f20fd211cc6a731033285b5b6b2f92df8628b32c9ad732713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Corynebacterium diphtheriae</topic><topic>Diphtheria - diagnosis</topic><topic>Disk Diffusion Antimicrobial Tests</topic><topic>Female</topic><topic>Fever</topic><topic>Fusobacterium Infections - diagnosis</topic><topic>Fusobacterium necrophorum</topic><topic>Fusobacterium necrophorum - isolation & purification</topic><topic>Hospitals</topic><topic>Hospitals, District</topic><topic>Hospitals, General</topic><topic>Humans</topic><topic>Infant</topic><topic>Male</topic><topic>Medical Audit - methods</topic><topic>Middle Aged</topic><topic>Patients</topic><topic>Pharyngitis</topic><topic>Pharyngitis - microbiology</topic><topic>Pharynx - microbiology</topic><topic>Prevalence</topic><topic>Recurrence</topic><topic>Streptococcal infections</topic><topic>Streptococcal Infections - diagnosis</topic><topic>Streptococcus pyogenes - isolation & purification</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Amess, J.A.</creatorcontrib><creatorcontrib>O'neill, W.</creatorcontrib><creatorcontrib>Giollariabhaigh, Ni</creatorcontrib><creatorcontrib>Dytrych, J.K.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>UK & Ireland Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of biomedical science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Amess, J.A.</au><au>O'neill, W.</au><au>Giollariabhaigh, Ni</au><au>Dytrych, J.K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A six-month audit of the isolation of Fusobacterium necrophorum from patients with sore throat in a district general hospital</atitle><jtitle>British journal of biomedical science</jtitle><addtitle>Br J Biomed Sci</addtitle><date>2007-01-01</date><risdate>2007</risdate><volume>64</volume><issue>2</issue><spage>63</spage><epage>65</epage><pages>63-65</pages><issn>0967-4845</issn><eissn>2474-0896</eissn><abstract>Fusobacterium necrophorum is an obligate anaerobe believed to be a member of the normal flora of the human oropharangeal and urogenital tract. It has been associated with deep-seated infections and was first described in 1936 by Lemierre, a French microbiologist. There is now strong evidence to suggest that it is also a cause of recurrent sore throat and persistent sore throat syndrome (PSTS) without leading to full systemic infection. It is considered to be the second most common cause of sore throat after group A β-haemolytic streptococci. This study was performed over a six-month period (October 2004 to March 2005) at the Eastbourne District General Hospital. All throat swabs received in the laboratory are cultured routinely for haemolytic group A streptococci and pathogenic Corynebacteria spp. During the study period an extra fastidious anaerobic blood agar plate with neomycin was inoculated, with a 30 µg vancomycin disc placed at the junction of the second and third streaks. This was examined after 48 h for the presence of F. necrophorum. A total of 1157 swabs were processed during the study period: 156 were positive for haemolytic group A streptococci, 57 were positive for F. necrophorum, 47 for group C haemolytic streptococci, nine for group G haemolytic streptococci, and one was positive for C. ulcerans. Patient age ranged from less than a year old to 88. The majority of F. necrophorum isolates were from patients in the 11-25 age group, with an isolation rate of 9.48% (44/464). This age group accounted for 40% (464/1157) of the swabs received during the study period and 77% (44/57) of these were positive for F. necrophorum. Group A haemolytic streptococci showed an overall isolation rate of 13.5%, with peaks of 23% in the 0-10 and 26-35 age ranges. Together, these two organisms were responsible for 18.4% (213/1157) of all throat infections in this study. The results presented here indicate that F. necrophorum is second to group A haemolytic streptococci as a cause of sore throat, especially in the young adult, and introduction of routine culture should be considered.</abstract><cop>England</cop><pub>Taylor & Francis</pub><pmid>17633139</pmid><doi>10.1080/09674845.2007.11732757</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0967-4845 |
ispartof | British journal of biomedical science, 2007-01, Vol.64 (2), p.63-65 |
issn | 0967-4845 2474-0896 |
language | eng |
recordid | cdi_crossref_primary_10_1080_09674845_2007_11732757 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
subjects | Adolescent Adult Aged Aged, 80 and over Child Child, Preschool Corynebacterium diphtheriae Diphtheria - diagnosis Disk Diffusion Antimicrobial Tests Female Fever Fusobacterium Infections - diagnosis Fusobacterium necrophorum Fusobacterium necrophorum - isolation & purification Hospitals Hospitals, District Hospitals, General Humans Infant Male Medical Audit - methods Middle Aged Patients Pharyngitis Pharyngitis - microbiology Pharynx - microbiology Prevalence Recurrence Streptococcal infections Streptococcal Infections - diagnosis Streptococcus pyogenes - isolation & purification Studies |
title | A six-month audit of the isolation of Fusobacterium necrophorum from patients with sore throat in a district general hospital |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T13%3A43%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20six-month%20audit%20of%20the%20isolation%20of%20Fusobacterium%20necrophorum%20from%20patients%20with%20sore%20throat%20in%20a%20district%20general%20hospital&rft.jtitle=British%20journal%20of%20biomedical%20science&rft.au=Amess,%20J.A.&rft.date=2007-01-01&rft.volume=64&rft.issue=2&rft.spage=63&rft.epage=65&rft.pages=63-65&rft.issn=0967-4845&rft.eissn=2474-0896&rft_id=info:doi/10.1080/09674845.2007.11732757&rft_dat=%3Cproquest_cross%3E1448299581%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=227920802&rft_id=info:pmid/17633139&rfr_iscdi=true |